Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Latent Tuberculosis | 5 | 2026 | 24 | 3.770 |
Why?
|
| Tuberculosis | 9 | 2026 | 306 | 3.540 |
Why?
|
| Communicable Disease Control | 2 | 2019 | 40 | 1.110 |
Why?
|
| Rhode Island | 6 | 2026 | 110 | 1.020 |
Why?
|
| Global Health | 4 | 2025 | 181 | 1.010 |
Why?
|
| Primary Health Care | 4 | 2026 | 722 | 1.000 |
Why?
|
| Awards and Prizes | 1 | 2026 | 31 | 0.950 |
Why?
|
| Mentoring | 1 | 2026 | 63 | 0.890 |
Why?
|
| Antitubercular Agents | 2 | 2023 | 82 | 0.880 |
Why?
|
| Community Health Centers | 1 | 2025 | 98 | 0.870 |
Why?
|
| Diabetes, Gestational | 1 | 2025 | 142 | 0.800 |
Why?
|
| Isoniazid | 2 | 2021 | 11 | 0.700 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2021 | 120 | 0.600 |
Why?
|
| Epidemics | 1 | 2019 | 27 | 0.590 |
Why?
|
| Mobile Applications | 1 | 2021 | 140 | 0.590 |
Why?
|
| Developing Countries | 3 | 2025 | 87 | 0.570 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2023 | 418 | 0.560 |
Why?
|
| Kenya | 7 | 2022 | 97 | 0.550 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 801 | 0.500 |
Why?
|
| Health Services Accessibility | 2 | 2019 | 593 | 0.500 |
Why?
|
| Mass Screening | 5 | 2022 | 698 | 0.490 |
Why?
|
| Family Practice | 3 | 2025 | 216 | 0.480 |
Why?
|
| Child | 8 | 2022 | 4612 | 0.470 |
Why?
|
| Biomedical Research | 2 | 2025 | 262 | 0.460 |
Why?
|
| Internship and Residency | 1 | 2022 | 805 | 0.420 |
Why?
|
| HIV Infections | 1 | 2021 | 955 | 0.410 |
Why?
|
| Humans | 22 | 2026 | 65121 | 0.400 |
Why?
|
| Manipulation, Osteopathic | 1 | 2011 | 2 | 0.340 |
Why?
|
| Osteopathic Medicine | 1 | 2011 | 9 | 0.340 |
Why?
|
| Adolescent | 6 | 2022 | 6305 | 0.280 |
Why?
|
| Adult | 8 | 2025 | 17356 | 0.270 |
Why?
|
| Surveys and Questionnaires | 3 | 2026 | 2763 | 0.260 |
Why?
|
| Clinical Competence | 2 | 2022 | 727 | 0.250 |
Why?
|
| Retrospective Studies | 3 | 2025 | 6862 | 0.240 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2022 | 767 | 0.240 |
Why?
|
| Authorship | 1 | 2025 | 25 | 0.220 |
Why?
|
| United States | 3 | 2022 | 8094 | 0.210 |
Why?
|
| Publishing | 1 | 2025 | 95 | 0.210 |
Why?
|
| Periodicals as Topic | 1 | 2025 | 178 | 0.190 |
Why?
|
| Rural Population | 2 | 2021 | 223 | 0.180 |
Why?
|
| Tuberculin Test | 1 | 2022 | 9 | 0.180 |
Why?
|
| Prevalence | 1 | 2025 | 1445 | 0.170 |
Why?
|
| Education, Medical, Continuing | 1 | 2022 | 92 | 0.170 |
Why?
|
| Telemedicine | 1 | 2026 | 363 | 0.170 |
Why?
|
| Antihypertensive Agents | 1 | 2022 | 179 | 0.170 |
Why?
|
| Vulnerable Populations | 1 | 2022 | 94 | 0.170 |
Why?
|
| Vaccination | 2 | 2021 | 375 | 0.160 |
Why?
|
| Financing, Personal | 1 | 2020 | 23 | 0.160 |
Why?
|
| Vaccines | 1 | 2021 | 96 | 0.160 |
Why?
|
| Insurance Coverage | 1 | 2020 | 98 | 0.150 |
Why?
|
| Hypertension | 2 | 2022 | 612 | 0.150 |
Why?
|
| World Health Organization | 1 | 2019 | 35 | 0.150 |
Why?
|
| Education | 1 | 2020 | 66 | 0.150 |
Why?
|
| Language | 1 | 2021 | 154 | 0.150 |
Why?
|
| Female | 7 | 2026 | 34013 | 0.150 |
Why?
|
| Goals | 1 | 2019 | 96 | 0.140 |
Why?
|
| Parental Consent | 1 | 2018 | 6 | 0.140 |
Why?
|
| Disease Management | 1 | 2020 | 235 | 0.140 |
Why?
|
| Teaching | 1 | 2020 | 165 | 0.140 |
Why?
|
| Pregnancy | 1 | 2025 | 2374 | 0.140 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 126 | 0.140 |
Why?
|
| Health Services Research | 1 | 2019 | 265 | 0.140 |
Why?
|
| Curriculum | 1 | 2022 | 608 | 0.140 |
Why?
|
| Health Status Disparities | 1 | 2019 | 147 | 0.140 |
Why?
|
| Contact Tracing | 1 | 2017 | 17 | 0.130 |
Why?
|
| Quality Improvement | 1 | 2022 | 464 | 0.130 |
Why?
|
| Ultrasonography | 1 | 2020 | 489 | 0.130 |
Why?
|
| Papillomavirus Vaccines | 1 | 2018 | 69 | 0.130 |
Why?
|
| Health Personnel | 1 | 2021 | 385 | 0.130 |
Why?
|
| Attitude | 1 | 2017 | 101 | 0.130 |
Why?
|
| Infant | 2 | 2022 | 1693 | 0.120 |
Why?
|
| Papillomavirus Infections | 1 | 2018 | 134 | 0.120 |
Why?
|
| Social Stigma | 1 | 2017 | 78 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 433 | 0.120 |
Why?
|
| Child, Preschool | 2 | 2022 | 2061 | 0.120 |
Why?
|
| Pandemics | 1 | 2021 | 675 | 0.120 |
Why?
|
| Health Education | 1 | 2017 | 189 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 497 | 0.100 |
Why?
|
| Registries | 1 | 2017 | 919 | 0.100 |
Why?
|
| Qualitative Research | 1 | 2017 | 748 | 0.100 |
Why?
|
| Male | 5 | 2026 | 31039 | 0.090 |
Why?
|
| Health Promotion | 1 | 2017 | 516 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 1698 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2022 | 5785 | 0.080 |
Why?
|
| Musculoskeletal Diseases | 1 | 2011 | 104 | 0.080 |
Why?
|
| Income | 2 | 2021 | 169 | 0.080 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2020 | 151 | 0.070 |
Why?
|
| Developed Countries | 1 | 2025 | 16 | 0.060 |
Why?
|
| Bibliometrics | 1 | 2025 | 35 | 0.060 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2022 | 58 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2022 | 105 | 0.050 |
Why?
|
| Family Characteristics | 1 | 2021 | 46 | 0.040 |
Why?
|
| Young Adult | 2 | 2022 | 4810 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2022 | 199 | 0.040 |
Why?
|
| Family | 1 | 2022 | 245 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2022 | 526 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2022 | 882 | 0.040 |
Why?
|
| Self Report | 1 | 2020 | 391 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 555 | 0.030 |
Why?
|
| Physicians | 1 | 2020 | 477 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 2703 | 0.020 |
Why?
|
| Middle Aged | 1 | 2020 | 18264 | 0.010 |
Why?
|